CHARLES A REYNOLDS, MD
Marriage and Family Therapists at Marsha Sharp Fwy, Lubbock, TX
License number
Texas D9624
Category
Osteopathic Medicine
Type
Family Medicine
Address
Address
4515 Marsha Sharp Fwy, Lubbock, TX 79407
Phone
(806) 744-7223
(806) 740-3325 (Fax)
(806) 740-3325 (Fax)
Personal information
See more information about CHARLES A REYNOLDS at radaris.comName
Address
Phone
4913 Cummings Dr, N Richlnd Hls, TX 76180
4302 Boulder Dr, Midland, TX 79707
4613 Chocorio Rd, Alvin, TX 77511
4503 Texana, Baytown, TX 77523
Organization information
See more information about CHARLES A REYNOLDS at bizstanding.comCharles Reynolds MD
4515 Marsha Sharp Fwy, Lubbock, TX 79407
Industry:
Family Doctor
Site:
Phone:
(806) 744-7223 (Phone)
Charles A. Reynolds Iv
Professional information
Dr. Charles A Reynolds - MD (Doctor of Medicine)
Hospitals:
Grace Clinic
4515 Marsha Sharp Fwy, Lubbock 79407
Covenant Medical Center - 19th Street
3615 19Th St, Lubbock 79410
Grace Clinic
4515 Marsha Sharp Fwy, Lubbock 79407
Covenant Medical Center - 19th Street
3615 19Th St, Lubbock 79410
4515 Marsha Sharp Fwy, Lubbock 79407
Covenant Medical Center - 19th Street
3615 19Th St, Lubbock 79410
Grace Clinic
4515 Marsha Sharp Fwy, Lubbock 79407
Covenant Medical Center - 19th Street
3615 19Th St, Lubbock 79410
Education:
Medical Schools
University Of Texas Medical School At San Antonio
Graduated: 1972
University Of Texas Medical School At San Antonio
Graduated: 1972
Charles W Reynolds, Powell TN
Specialties:
Urology, Family Medicine
Work:
Tennesee Urology Associates
7557 Dannaher Way, Powell, TN 37849 Grace Clinic of Lubbock
4515 Marsha Sharp Fwy, Lubbock, TX 79407
7557 Dannaher Way, Powell, TN 37849 Grace Clinic of Lubbock
4515 Marsha Sharp Fwy, Lubbock, TX 79407
Education:
University of Tennessee (1977)
Charles A Reynolds, Lubbock TX
Specialties:
Family Physician
Address:
2804 N Loop 289, Lubbock, TX 79415
4515 Marsha Sharp Fwy, Lubbock, TX 79407
4515 Marsha Sharp Fwy, Lubbock, TX 79407
Education:
University of Texas (San Antonio), Medical School - Doctor of Medicine
Compositions And Methods For Treating Hyperproliferative Disorders
US Patent:
2011015, Jun 23, 2011
Filed:
Nov 12, 2010
Appl. No.:
12/945808
Inventors:
Barry James Maurer - Idalou TX, US
Charles Patrick Reynolds - Lubbock TX, US
Charles Patrick Reynolds - Lubbock TX, US
International Classification:
A61K 31/5375, C07C 215/24, A61K 31/167, A61P 35/00
US Classification:
5142388, 564506, 514613
Abstract:
A method of treating a hyperproliferative disorder in a subject in need of such treatment, comprising administering to said subject, in combination, a treatment effective amount of: (a) a ceramide-increasing retinoid such as fenretinide or a pharmaceutically acceptable salt thereof; and (b) at least one (and in certain embodiments at least two) compounds selected from the groups consisting of (i) a non-18 carbon chain length L-threo-sphinganine(s) or pharmaceuticeutically acceptable salt thereof, (ii) glucosylceramide or glucosyl(dihydro)ceramide synthesis inhibitor(s), and (iii) sphingomyelin or dihydrosphingomyelin synthase inhibitor(s). Preferred L-threo-sphinganines are of carbon chain length 17 carbons, 19 carbons and 20 carbons. A preferred glucosylceramide or glucosyl(dihydro)ceramide synthesis inhibitor is D-threo-1-phenyl-2-palmitoylamino-3-morpholino-1-propanol. A preferred sphingomyelin or dihydrosphingomyelin synthesis inhibitor is D-threo-1-phenyl-2-palmitoylamino-3-morpholino-1-propanol. A preferred hyperproliferative disorder is brain cancers.
Compositions And Methods For Treating Hyperproliferative Disorders
US Patent:
2013021, Aug 22, 2013
Filed:
Apr 3, 2013
Appl. No.:
13/856015
Inventors:
Texas Tech University System - , US
Charles Patrick Reynolds - Lubbock TX, US
Charles Patrick Reynolds - Lubbock TX, US
Assignee:
Texas Tech University System - Lubbock TX
International Classification:
A61K 31/133, A61K 31/5375, A61K 31/167
US Classification:
5142378, 564507, 514613, 514669
Abstract:
A method of treating a hyperproliferative disorder in a subject in need of such treatment, comprising administering to said subject, in combination, a treatment effective amount of: (a) a ceramide-increasing retinoid such as fenretinide or a pharmaceutically acceptable salt thereof; and (b) at least one (and in certain embodiments at least two) compounds selected from the groups consisting of (i) a non-18 carbon chain length L-threo-sphinganine(s) or pharmaceuticeutically acceptable salt thereof, (ii) glucosylceramide or glucosyl(dihydro)ceramide synthesis inhibitor(s), and (iii) sphingomyelin or dihydrosphingomyelin synthase inhibitor(s). Preferred L-threo-sphinganines are of carbon chain length 17 carbons, 19 carbons and 20 carbons. A preferred glucosylceramide or glucosyl(dihydro)ceramide synthesis inhibitor is D-threo-1-phenyl-2-palmitoylamino-3-morpholino-1-propanol. A preferred sphingomyelin or dihydrosphingomyelin synthesis inhibitor is D-threo-1-phenyl-2-palmitoylamino-3-morpholino-1-propanol. A preferred hyperproliferative disorder is brain cancers.
Metabolic Degradation Inhibitors For Anti-Hyperproliferative Agents
US Patent:
2010031, Dec 9, 2010
Filed:
Sep 26, 2008
Appl. No.:
12/679795
Inventors:
Barry James Maurer - Idalou TX, US
Charles Patrick Reynolds - Lubbock TX, US
Charles Patrick Reynolds - Lubbock TX, US
International Classification:
A61K 31/4164, A61K 31/496, A61K 31/4196, A61K 31/16, A61P 35/04
US Classification:
51425407, 514396, 514383, 514613
Abstract:
The present invention provides methods of increasing an amount of a treatment agent in the body, a cancer or tumor. The methods include administering an inhibitor of the metabolic degradation or conversion of the treatment agent to a subject undergoing treatment for a hyperproliferative disorder with said treatment agent. Methods of treating hyperproliferative disorders, tumors and cancers are also provided.